PREVENTIVE ONCOLOGY ACADEMIC AWARD
预防肿瘤学学术奖
基本信息
- 批准号:2084125
- 负责人:
- 金额:$ 9.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-07-01 至 1996-06-30
- 项目状态:已结题
- 来源:
- 关键词:DNA replication adenocarcinoma blood donor cancer prevention cancer risk colon neoplasms environment related neoplasm /cancer enzyme linked immunosorbent assay ferritin human morbidity human subject iron storage disorder neoplasm /cancer education neoplasm /cancer epidemiology nucleic acid probes preneoplastic state questionnaires restriction fragment length polymorphism serum
项目摘要
One of the biggest challenges facing Preventive Oncology today is the
better definition of high risk individuals. An ever growing body of data
is transmitted to the public concerning cancer causation. This bombardment
of information, while broadening our understanding, serves us poorly if
conveys the impression that everything is carcinogenic and that the risk
is universal. Preventive Oncology must begin to send the message that it
is the rare exposure that is absolutely carcinogenic. We cannot consider
the exposure without equal consideration of the genetic background which
it affects. The challenge, then, is to find ways of identifying the
susceptible subset of the population.
I believe that susceptibility will increasingly be identified by
biochemical means and the scientists who will move to the forefront in this
identification are biochemical epidemiologists. In this emerging field,
it is necessary to equip researchers with both the discipline of
epidemiology and the skill of laboratory science. This award would provide
me with the perfect opportunity to move into that arena.
The training program which I have proposed will increase my skills in
all areas of molecular oncology. I have chosen the laboratories and
courses to complement each other and fill in those areas most necessary to
a well founded biochemical epidemiologist. I will continue to teach during
the course of the award, and hope stimulate the thinking of future
researchers in this field. I have outlined a research program, based on
the relationship between body iron stores and cancer susceptibility, which
promises to serve as the starting point for a larger, more diverse program
of biological susceptibility. This award will allow me to complete the
necessary training, continue teaching, and launch a program which, I feel,
will likely prove to be of great value to Preventive Oncology.
当今预防肿瘤学面临的最大挑战之一是
更好地定义高危人群。 不断增长的数据体
传播给公众有关癌症的原因。 这次轰炸
信息,虽然扩大了我们的理解,为我们服务不好,
给人的印象是一切都是致癌的,
是普遍的。 预防肿瘤学必须开始发出这样的信息,
是绝对致癌的罕见接触。 我们不能认为
没有平等考虑遗传背景的暴露,
它影响。 因此,挑战在于找到识别
人群中的易感亚群。
我相信,易感性将越来越多地被确定为
生物化学手段和科学家谁将移动到最前沿,
鉴定是生化流行病学家。 在这一新兴领域,
有必要使研究人员具备以下两个学科:
流行病学和实验室科学技能。 该奖项将提供
给我一个进入那个竞技场的绝佳机会
我所建议的培训计划将提高我在以下方面的技能
分子肿瘤学的所有领域。 我选择了实验室,
课程相辅相成,填补那些最必要的领域,
一位有充分根据的生化流行病学家 我会继续教,
获奖的过程,并希望激发对未来的思考
该领域的研究人员。 我已经概述了一个研究计划,基于
体内铁储存与癌症易感性之间的关系,
承诺作为一个更大,更多样化的计划的起点
生物易感性的证据 这个奖项将使我能够完成
必要的培训,继续教学,并启动一个项目,我觉得,
很可能对预防肿瘤学有很大的价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHERINE A MCGLYNN其他文献
KATHERINE A MCGLYNN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHERINE A MCGLYNN', 18)}}的其他基金
EPIDEMIOLOGY OF BODY IRON STORES AND COLONIC POLYPS
体内铁储备和结肠息肉的流行病学
- 批准号:
2095714 - 财政年份:1992
- 资助金额:
$ 9.18万 - 项目类别:
EPIDEMIOLOGY OF BODY IRON STORES AND COLONIC POLYPS
体内铁储备和结肠息肉的流行病学
- 批准号:
2095713 - 财政年份:1992
- 资助金额:
$ 9.18万 - 项目类别:
EPIDEMIOLOGY OF BODY IRON STORES AND COLONIC POLYPS
体内铁储备和结肠息肉的流行病学
- 批准号:
2095712 - 财政年份:1992
- 资助金额:
$ 9.18万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 9.18万 - 项目类别:














{{item.name}}会员




